about
Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.Percutaneous Closure of Post-Infarction Ventricular Septal Defects-An Over Decade-long Experience.Outcome prediction following transcatheter aortic valve implantation: Multiple risk scores comparison.Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantationLeft ventricular remodelling pattern and its relation to clinical outcomes in patients with severe aortic stenosis treated with transcatheter aortic valve implantation.Augmented reality in left atrial appendage occlusion.Thromboelastography for predicting bleeding in patients with aortic stenosis treated with TAVI.Patient-prosthesis mismatch in patients treated with transcatheter aortic valve implantation - predictors, incidence and impact on clinical efficacy. A preliminary study.Percutaneous closure of an aortopulmonary window using Amplatzer Duct Occluder II: Additional Sizes: the first reported case.Simultaneous acute closure of the right coronary artery and left anterior descending artery in a young male.Repeated graft loss after orthotopic liver transplantation: a case reportPlatelet distribution width predicts left ventricular dysfunction in patients with acute coronary syndromes treated with percutaneous coronary interventionMain pulmonary artery perforations after left atrial appendage occluder implantationPercutaneous pulmonary valve implantation in patients after Ross procedure: role of intravascular ultrasoundPre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacementTranscatheter aortic valve implantation in patients with bicuspid aortic valve stenosis utilizing the next-generation fully retrievable and repositionable valve system: mid-term results from a prospective multicentre registry
P50
Q38607422-6B05E3DF-4B6A-4DD7-8C98-AC3EFF907CFDQ39025586-48C880A5-CF2D-4098-9BA2-608478E9ACB6Q40164383-5B991DB4-8A24-4099-B54E-C5BE4A93646FQ42360028-0CF3801D-FB38-49F0-A644-6F7205CEE353Q49329568-516300CA-C9D5-4752-9FA8-0C44FEF66599Q49331184-527384C0-A5CD-4248-9F4D-A55D093BC656Q49383005-F4C95613-963B-464C-B504-A75084DD58A5Q49533724-9A824C94-235C-481C-9CF7-B7F88D7C7E7AQ51096045-EDD999CE-2CB6-4F75-9697-EA548EA7A488Q53626768-1FC758B1-F554-499F-9AD9-C9A38AE07DDEQ84488962-EC6A66C6-32A3-4BF7-BAE6-4DD1F81A13A1Q88506941-7FA722C2-987B-43FB-9FF0-98924B36A711Q89403713-74ECEC97-F4A0-4A69-9AA8-B94A0057D4FEQ90676887-03F08D41-F4EC-47B0-86E3-505B558884DAQ92269724-C0685A63-5F1F-4730-83F6-4A3EC2083A2AQ93065837-793174F7-1215-45EB-9CAB-D3E38199F581
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Karol Zbroński
@en
Karol Zbroński
@nl
type
label
Karol Zbroński
@en
Karol Zbroński
@nl
prefLabel
Karol Zbroński
@en
Karol Zbroński
@nl
P31
P496
0000-0002-4428-8208